Research Article| Volume 37, ISSUE 3, P209-211, February 01, 1995

No association between length of the (CAG)n repeat of the huntington's disease gene and tourette's syndrome

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        3rd ed rev. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington DC1987
        • Cohen DJ
        • Leckman JF
        Developmental psychopathology and neurobiology of Tourette's syndrome.
        J Am Acad Child Adolesc Psychiatry. 1994; 33: 2-15
        • Duyao M
        • Ambrose C
        • Myers R
        • et al.
        Trinucleotide repeat length instability and age of onset in Huntington's disease.
        Nat Genet. 1993; 4: 387-392
        • Falk CT
        • Rubinstein P
        Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations.
        Ann Hum Genet. 1987; 51: 227-233
        • Harris GJ
        • Pearlson GD
        • Peyser CE
        • et al.
        Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
        Ann Neurol. 1992; 31: 69-75
        • Hebebrand J
        • Nöthen MM
        • Lehmkuhl G
        • et al.
        Tourette's syndrome and homozygosity for the dopamine D3 receptor gene.
        Lancet. 1993; 341: 1483
        • MacDonald ME
        • Ambrose CM
        • Duyao MP
        • and other members of the Huntington's Disease Collaborative Research Group
        A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes.
        Cell. 1993; 72: 971-983
        • Nöthen MM
        • Hebebrand J
        • Knapp M
        • et al.
        Association analysis of the dopamine D2 receptor gene in Tourette's syndrome using the haplotype relative risk method.
        Neuropsychiatric Genetics. 1994; 54: 249-252
        • Peterson BS
        • Riddle MA
        • Cohen DJ
        • et al.
        Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques 'from magnetic resonance images.
        Neurology. 1993; 43: 941-949
        • Riess O
        • Noerromoelle A
        • Soerensen SA
        • Epplen JT
        Improved PCR conditions for the stretch of (CAG)n repeats causing Huntington's disease.
        Hum Mol Genet. 1993; 2: 637
        • Singer HS
        • Reiss AL
        • Brown JE
        • et al.
        Volumetric MRI changes in basal ganglia of children with Tourette's syndrome.
        Neurology. 1993; 43: 950-956
        • Snell RG
        • MacMillan JC
        • Cheadle JP
        • et al.
        Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
        Nat Genet. 1993; 4: 393-397
        • Terwilliger JD
        • Ott J
        A haplotype-based “haplotype relative risk” approach to detecting allelic associations.
        Hum Hered. 1992; 42: 337-346